# OnCo record nct02674568 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02674568/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02674568", "NCT02674568" ;
  schema:name "Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer"@en ;
  schema:description "A phase 2 trial of Rovalpituzumab tesirine in Small-cell lung cancer, run by AbbVie, completed."@en ;
  schema:url <https://onco.cc/trials/nct02674568/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02674568> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/sclc/> ;
  onco:drugs <https://onco.cc/drugs/rovalpituzumab-tesirine/> ;
  onco:companies <https://onco.cc/companies/abbvie/> .